Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PDT, TRI, MAT

KALY Evaluates Patented Cannabis Extract for Potential Coronavirus Treatment


DALLAS, March 2, 2020 /PRNewswire/ -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) ("KALY") today again confirmed efforts to evaluate its proprietary CBD extract formulation as a treatment for coronavirus symptoms. KALY's proprietary CBD formulation has been developed for the treatment of symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions. The formulation for the treatment of symptoms associated with COPD and other similar respiratory conditions has been derived from the company's U.S. Patented Cannabis Extraction Process. As detailed in a recently published research study (Journal of Cannabis Research) the KALY U.S. Patented CBD extract provides significant anti-inflammatory responses in vitro.  The next phase of research is now moving forward in preclinical in vivo research to expand evaluation of the effects on lung function, total body distribution, whole body clearance of the extract and dosage evaluations for maximal efficacy. KALY has filed a new patent application specifically on its CBD formulation for symptoms associated with COPD and other similar respiratory conditions. KALY has also filed for a trademark on the name RespRx as the brand name for its CBD formulation to treat the symptoms associated with COPD and other similar respiratory conditions that result from respiratory inflammation.

To learn more about RespRx, visit https://www.resprx.com/

Follow further developments at

https://www.kali-extracts.com/

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.

CONTACT:
Frederick Ferri
ir@kali-extracts.com
+1 (214) 210-0459

SOURCE Kali-Extracts, Inc.


These press releases may also interest you

at 09:05
Community Care Cooperative (C3), the Accountable Care Organization (ACO) that advances community-based care for MassHealth members through its network of 19 health centers throughout the state, today announced the launch of a $5 million campaign to...

at 09:05
Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced that it had completed software changes and documentation required by the Chinese FDA for...

at 09:05
Two Bit Circus Foundation, a nonprofit educational organization, announced today it is collaborating with the Annenberg Foundation's educational division, Annenberg Learner, to provide free access to over 150 hands-on science, arts, and tech projects...

at 09:05
Openbay, Inc. an industry-leading automotive service marketplace and SaaS company, today announced integration between its AI-powered online chat platform, Otis, and TireShop by Freedomsoft. From within a chat window on an automotive service website,...

at 09:05
Continuing support for Texas communities impacted by COVID-19, Reliant announced today a donation of $100,000 to be shared by four local DFW organizations that are providing critical resources to communities in the metroplex. As part of Reliant's...

at 09:05
Reliant announced today a $130,000 donation to Houston Methodist to create the "Reliant Innovation Fund," enabling critical care innovations that will drive the future of healthcare in a post COVID-19 world. The Fund will be used to empower students...



News published on 2 march 2020 at 10:00 and distributed by: